• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者磁共振成像病灶计数数据的纵向模型。

A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients.

机构信息

Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada.

出版信息

Stat Med. 2012 Feb 28;31(5):449-69. doi: 10.1002/sim.4394. Epub 2011 Oct 3.

DOI:10.1002/sim.4394
PMID:21964585
Abstract

Magnetic resonance imaging (MRI) data are routinely collected at multiple time points during phase 2 clinical trials in multiple sclerosis. However, these data are typically summarized into a single response for each patient before analysis. Models based on these summary statistics do not allow the exploration of the trade-off between numbers of patients and numbers of scans per patient or the development of optimal schedules for MRI scanning. To address these limitations, in this paper, we develop a longitudinal model to describe one MRI outcome: the number of lesions observed on an individual MRI scan. We motivate our choice of a mixed hidden Markov model based both on novel graphical diagnostic methods applied to five real data sets and on conceptual considerations. Using this model, we compare the performance of a number of different tests of treatment effect. These include standard parametric and nonparametric tests, as well as tests based on the new model. We conduct an extensive simulation study using data generated from the longitudinal model to investigate the parameters that affect test performance and to assess size and power. We determine that the parameters of the hidden Markov chain do not substantially affect the performance of the tests. Furthermore, we describe conditions under which likelihood ratio tests based on the longitudinal model appreciably outperform the standard tests based on summary statistics. These results establish that the new model is a valuable practical tool for designing and analyzing multiple sclerosis clinical trials.

摘要

磁共振成像(MRI)数据在多发性硬化症的 2 期临床试验中通常会在多个时间点进行采集。然而,这些数据通常会在分析前汇总为每个患者的单个反应。基于这些汇总统计数据的模型不允许探索患者数量和每位患者扫描次数之间的权衡,也无法制定最佳的 MRI 扫描计划。为了解决这些限制,在本文中,我们开发了一个纵向模型来描述一个 MRI 结果:个体 MRI 扫描中观察到的病变数量。我们选择基于混合隐马尔可夫模型的理由既基于应用于五个真实数据集的新颖图形诊断方法,也基于概念性考虑。使用该模型,我们比较了许多不同治疗效果检验的性能。这些检验包括标准的参数和非参数检验,以及基于新模型的检验。我们使用从纵向模型生成的数据进行了广泛的模拟研究,以研究影响检验性能的参数,并评估其大小和功效。我们确定隐马尔可夫链的参数不会显著影响检验的性能。此外,我们描述了基于纵向模型的似然比检验明显优于基于汇总统计数据的标准检验的条件。这些结果表明,新模型是设计和分析多发性硬化症临床试验的有价值的实用工具。

相似文献

1
A longitudinal model for magnetic resonance imaging lesion count data in multiple sclerosis patients.多发性硬化症患者磁共振成像病灶计数数据的纵向模型。
Stat Med. 2012 Feb 28;31(5):449-69. doi: 10.1002/sim.4394. Epub 2011 Oct 3.
2
Power analyses for negative binomial models with application to multiple sclerosis clinical trials.应用于多发性硬化症临床试验的负二项式模型的功效分析。
J Biopharm Stat. 2012;22(2):237-59. doi: 10.1080/10543406.2010.528105.
3
Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials.长间隔 T2 加权减影磁共振成像:多发性硬化症临床试验中的有力新结局指标。
Ann Neurol. 2010 May;67(5):667-75. doi: 10.1002/ana.21958.
4
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint.多发性硬化症中以钆增强病变为终点的 I/II 期临床试验的优化设计与分析。
Mult Scler. 2010 Jul;16(7):840-7. doi: 10.1177/1352458510371409. Epub 2010 Jun 7.
5
An entropy-based nonparametric test for the validation of surrogate endpoints.基于熵的替代终点验证的非参数检验。
Stat Med. 2012 Jun 30;31(14):1517-30. doi: 10.1002/sim.4500. Epub 2012 Feb 17.
6
Longitudinal analyses for magnetic resonance imaging outcomes in multiple sclerosis clinical trials.
J Biopharm Stat. 1997 Nov;7(4):501-31. doi: 10.1080/10543409708835204.
7
Application of hidden Markov models to multiple sclerosis lesion count data.隐马尔可夫模型在多发性硬化症病灶计数数据中的应用。
Stat Med. 2005 Aug 15;24(15):2335-44. doi: 10.1002/sim.2108.
8
A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients.一种用于检测个体多发性硬化症患者MRI病变计数异常增加的灵活混合效应负二项回归模型。
Stat Med. 2015 Jun 15;34(13):2165-80. doi: 10.1002/sim.6484. Epub 2015 Mar 18.
9
Hypothesis testing in semiparametric additive mixed models.半参数加法混合模型中的假设检验
Biostatistics. 2003 Jan;4(1):57-74. doi: 10.1093/biostatistics/4.1.57.
10
Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients.多发性硬化症中强化病灶演变模式在患者体内是一致的。
Neurology. 2005 Jul 12;65(1):56-61. doi: 10.1212/01.wnl.0000167538.24338.bb.

引用本文的文献

1
MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.基于 MRI 的支持向量机和病灶形态学预测临床孤立综合征向临床确诊多发性硬化的转化。
Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.
2
Exposure-disease response analysis of natalizumab in subjects with multiple sclerosis.那他珠单抗在多发性硬化症患者中的暴露-疾病反应分析。
J Pharmacokinet Pharmacodyn. 2017 Jun;44(3):263-275. doi: 10.1007/s10928-017-9514-4. Epub 2017 Mar 1.
3
Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients.
复发缓解型多发性硬化症患者中聚乙二醇化干扰素β-1a暴露量与钆增强病变或T2病变反应的分析
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):371-83. doi: 10.1007/s10928-016-9477-x. Epub 2016 Jun 14.